Related Experiment Video
Updated: May 3, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
20.3K
Dolutegravir: an exciting new kid on the block
Jose Luis Blanco Arévalo1, Gary George Whitlock
1University of Barcelona, IDIBAPS, Hospital Clinic , Barcelona , Spain JLBLANCO@clinic.ub.es.
Expert Opinion on Pharmacotherapy
|January 23, 2014
Summary
Dolutegravir, a second-generation integrase inhibitor, is safe and effective for HIV treatment in both new and experienced patients. It shows a higher genetic barrier to resistance compared to older integrase inhibitors.
Area of Science:
- Pharmacology
- Virology
- Clinical Medicine
Background:
- Dolutegravir represents a significant advancement as a second-generation integrase inhibitor.
- It is approved for treating both individuals newly diagnosed with HIV and those with prior treatment experience.
Purpose of the Study:
- To review existing data on dolutegravir's pharmacokinetic profile.
- To assess the efficacy, safety, tolerability, and resistance patterns of dolutegravir.
Main Methods:
- Literature review of in vitro studies.
- Analysis of Phase II and III clinical trial data.
- Inclusion of data from international meetings and PubMed publications.
Main Results:
- Dolutegravir demonstrates favorable pharmacokinetics.
- Clinical trials indicate high efficacy and good tolerability in diverse patient groups.
- Safety profiles are consistent across studies.
Conclusions:
- Dolutegravir is a safe and well-tolerated treatment option for HIV.
- It exhibits high efficacy in both antiretroviral-naïve and treatment-experienced individuals.
- The drug presents a higher genetic barrier to resistance than first-generation integrase inhibitors.
More Related Videos
Related Concept Videos
02:33Retroviruses
12.1K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.1K
01:29Subviral Agents
933
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
933
01:30Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
01:28Viral Hepatitis I: Introduction
25
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
01:10Retrovirus Life Cycles
43.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
01:16Therapeutic Drug Monitoring: Overview and Classification
642
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
642